chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: covid arm; Itchy swelling at injection site; very hot; enormous rash 3 inches; burning; bright red; terrible itch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (very hot), VACCINATION SITE REACTION (covid arm), VACCINATION SITE PRURITUS (terrible itch at injection site), VACCINATION SITE RASH (enormous rash 3 inches) and INJECTION SITE PAIN (burning) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (terrible itch at injection site). On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (very hot), VACCINATION SITE RASH (enormous rash 3 inches), INJECTION SITE PAIN (burning) and VACCINATION SITE ERYTHEMA (bright red). On an unknown date, the patient experienced VACCINATION SITE REACTION (covid arm) and VACCINATION SITE SWELLING (Itchy swelling at injection site). At the time of the report, VACCINATION SITE WARMTH (very hot), VACCINATION SITE REACTION (covid arm), VACCINATION SITE PRURITUS (terrible itch at injection site), VACCINATION SITE RASH (enormous rash 3 inches), INJECTION SITE PAIN (burning) and VACCINATION SITE ERYTHEMA (bright red) had resolved and VACCINATION SITE SWELLING (Itchy swelling at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-261489 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up received included event outcome COVID arm was updated from unknown to recovered. On 20-Jul-2021: Follow up received included patient demographics, additional event(Itchy swelling at injection site) were updated.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for Covid 19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Tested positive for Covid 19) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for Covid 19). At the time of the report, COVID-19 (Tested positive for Covid 19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Vomiting
Clinical narrative: stomach cramps and throwing up; stomach cramps and throwing up; A spontaneous report was received from a consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events stomach cramps and throwing up,  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) stomach cramps and throwing up.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), stomach cramps and throwing up was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: red; itchy; It is going up the arm now: 3 in length wise; 1.5 in diameter rash around the injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE RASH (1.5 in diameter rash around the injection site), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE RASH (It is going up the arm now: 3 in length wise) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included TRAZODONE for Sleep difficult.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE RASH (1.5 in diameter rash around the injection site). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE RASH (It is going up the arm now: 3 in length wise). At the time of the report, VACCINATION SITE RASH (1.5 in diameter rash around the injection site), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE RASH (It is going up the arm now: 3 in length wise) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: site of injection has red mark; Site of injection has itchiness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Site of injection has itchiness) and VACCINATION SITE ERYTHEMA (site of injection has red mark) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Site of injection has itchiness). On 02-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (site of injection has red mark). At the time of the report, VACCINATION SITE PRURITUS (Site of injection has itchiness) and VACCINATION SITE ERYTHEMA (site of injection has red mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. Treatment medication include cortisone cream   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up received on 03-JUN-2021 contains no new information.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling, Pain in extremity, Peripheral swelling
Clinical narrative: Left wrist pain; Left wrist swelling; Left hand pain; Left hand swelling; A spontaneous report was received from a consumer concerning a 81-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events left wrist pain, left wrist swelling, left hand pain, left hand swelling.  The patient's medical history was not provided. Concomitant medications reported were Citalopran, Tansulosin, Esomeprazol, Evothyroxine for drug use for unknown indication.  On 24 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 002821a) intramuscularly for prophylaxis of COVID-19 infection.  On 26 Feb 2021, the patient experienced the event(s) left wrist pain, left wrist swelling, left hand pain, left hand swelling.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), left wrist pain, left wrist swelling, left hand pain, left hand swelling was unknown.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: they were loosing their taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (they were loosing their taste) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced AGEUSIA (they were loosing their taste). On 01-Mar-2021, AGEUSIA (they were loosing their taste) had resolved.            Action taken with vaccine was not applicable. Treatment and  concomitant medication were not provided by the reporter
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Tested positive for Covid-19; A spontaneous report was received from a consumer concerning a 76-years-old male patient who received first dose of Moderna's COVID-19 vaccine (mRNA-1273) and experienced events  tested positive for covid-19/SARS-CoV-2 test positive.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 5 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 010M20A) via unknown route in his left arm for prophylaxis of COVID-19 infection.On 25 Feb 2021, the patient was tested positive for covid-19.No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of event tested positive for covid-19 was unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Fatigue, Pain, Palpitations
Clinical narrative: weakness; her symptoms were getting progressively worse; second episode being worse then what it was the first time; shortness of breath; heart palpitations; pain; extreme fatigue, fatigue, fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), PALPITATIONS (heart palpitations), PAIN (pain ), FATIGUE (extreme fatigue, fatigue, fatigue) and ASTHENIA (weakness) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced DYSPNOEA (shortness of breath), PALPITATIONS (heart palpitations), PAIN (pain ), FATIGUE (extreme fatigue, fatigue, fatigue), ASTHENIA (weakness), PAIN (her symptoms were getting progressively worse) and SYMPTOM RECURRENCE (second episode being worse then what it was the first time). At the time of the report, DYSPNOEA (shortness of breath), PALPITATIONS (heart palpitations), PAIN (pain ), FATIGUE (extreme fatigue, fatigue, fatigue), ASTHENIA (weakness), PAIN (her symptoms were getting progressively worse) and SYMPTOM RECURRENCE (second episode being worse then what it was the last time) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Symptom recurrence
Clinical narrative: weakness; her symptoms were getting progressively worse; second episode being worse then what it was the first time; shortness of breath; heart palpitations; pain; extreme fatigue, fatigue, fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), PALPITATIONS (heart palpitations), PAIN (pain ), FATIGUE (extreme fatigue, fatigue, fatigue) and ASTHENIA (weakness) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced DYSPNOEA (shortness of breath), PALPITATIONS (heart palpitations), PAIN (pain ), FATIGUE (extreme fatigue, fatigue, fatigue), ASTHENIA (weakness), PAIN (her symptoms were getting progressively worse) and SYMPTOM RECURRENCE (second episode being worse then what it was the first time). At the time of the report, DYSPNOEA (shortness of breath), PALPITATIONS (heart palpitations), PAIN (pain ), FATIGUE (extreme fatigue, fatigue, fatigue), ASTHENIA (weakness), PAIN (her symptoms were getting progressively worse) and SYMPTOM RECURRENCE (second episode being worse then what it was the last time) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Electrocardiogram, Hypertension, Myalgia, Pruritus
Clinical narrative: chest pain; high blood pressure; generalized muscle soreness; delayed itching; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYALGIA (generalized muscle soreness), PRURITUS (delayed itching), HYPERTENSION (high blood pressure) and CHEST PAIN (chest pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced MYALGIA (generalized muscle soreness) and PRURITUS (delayed itching). On 22-Feb-2021, the patient experienced HYPERTENSION (high blood pressure). On 24-Feb-2021, the patient experienced CHEST PAIN (chest pain). At the time of the report, MYALGIA (generalized muscle soreness), PRURITUS (delayed itching), HYPERTENSION (high blood pressure) and CHEST PAIN (chest pain) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Electrocardiogram: normal Normal.         No Concomitant Medicines were included  Treatment medicines included Isosorbide Mononitrate 20mg which lasted for 3days.  This Friday patient is going to Stress Test
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Vaccination site erythema, Vaccination site swelling
Clinical narrative: red (arm); swollen (arm); It moved up and down the arm; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE ERYTHEMA (red (arm)), VACCINATION SITE SWELLING (swollen (arm)) and LIMB DISCOMFORT (It moved up and down the arm) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red (arm)), VACCINATION SITE SWELLING (swollen (arm)) and LIMB DISCOMFORT (It moved up and down the arm). At the time of the report, VACCINATION SITE ERYTHEMA (red (arm)), VACCINATION SITE SWELLING (swollen (arm)) and LIMB DISCOMFORT (It moved up and down the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD21-041738, MOD21-041784 (E2B Linked Report).; Sender's Comments:  MOD21-041738: MOD21-041784:
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Tachycardia
Clinical narrative: tachycardia; i just did not feel well.; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (tachycardia) and MALAISE (i just did not feel well.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TACHYCARDIA (tachycardia) and MALAISE (i just did not feel well.). At the time of the report, TACHYCARDIA (tachycardia) and MALAISE (i just did not feel well.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no treatment and concomitant product was reported For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: off and on sinus infections; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (off and on sinus infections) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (off and on sinus infections). At the time of the report, SINUSITIS (off and on sinus infections) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment and concomitant product was reported. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-046530 (Patient Link).   Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness, Myalgia, Pyrexia, Swelling
Clinical narrative: Patient noticed a huge lump on left side above shoulder blade and neck and right below left ear; Fever, chills, body aches, felt over all sick; Fever, chills, body aches, felt over all sick; Fever, chills, body aches, felt over all sick; Fever, chills, body aches, felt over all sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Fever, chills, body aches, felt over all sick), SWELLING (Patient noticed a huge lump on left side above shoulder blade and neck and right below left ear), PYREXIA (Fever, chills, body aches, felt over all sick), CHILLS (Fever, chills, body aches, felt over all sick) and MYALGIA (Fever, chills, body aches, felt over all sick) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced ILLNESS (Fever, chills, body aches, felt over all sick), PYREXIA (Fever, chills, body aches, felt over all sick), CHILLS (Fever, chills, body aches, felt over all sick) and MYALGIA (Fever, chills, body aches, felt over all sick). On 28-Feb-2021, the patient experienced SWELLING (Patient noticed a huge lump on left side above shoulder blade and neck and right below left ear). At the time of the report, ILLNESS (Fever, chills, body aches, felt over all sick), SWELLING (Patient noticed a huge lump on left side above shoulder blade and neck and right below left ear), PYREXIA (Fever, chills, body aches, felt over all sick), CHILLS (Fever, chills, body aches, felt over all sick) and MYALGIA (Fever, chills, body aches, felt over all sick) outcome was unknown.            no treatment product was reported The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Injection site mass, Swelling face, Vaccination site mass
Clinical narrative: the knot has increased in size to that of a baseball; tired feeling that went away but returned several days later; large, hard, round knot the size of a golf ball in arm that received injection; red, puffy face that went away but returned several days later; red, puffy face that went away but returned several days later; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (large, hard, round knot the size of a golf ball in arm that received injection), ERYTHEMA (red, puffy face that went away but returned several days later), SWELLING FACE (red, puffy face that went away but returned several days later), VACCINATION SITE MASS (the knot has increased in size to that of a baseball) and FATIGUE (tired feeling that went away but returned several days later) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 667M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced INJECTION SITE MASS (large, hard, round knot the size of a golf ball in arm that received injection), ERYTHEMA (red, puffy face that went away but returned several days later), SWELLING FACE (red, puffy face that went away but returned several days later) and FATIGUE (tired feeling that went away but returned several days later). On an unknown date, the patient experienced VACCINATION SITE MASS (the knot has increased in size to that of a baseball). At the time of the report, INJECTION SITE MASS (large, hard, round knot the size of a golf ball in arm that received injection), ERYTHEMA (red, puffy face that went away but returned several days later), SWELLING FACE (red, puffy face that went away but returned several days later), VACCINATION SITE MASS (the knot has increased in size to that of a baseball) and FATIGUE (tired feeling that went away but returned several days later) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was reported No treatment information was provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Delayed reaction with a red itchy rash that spread; This spontaneous case was reported by a nurse and describes the occurrence of RASH PRURITIC (Delayed reaction with a red itchy rash that spread) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Delayed reaction with a red itchy rash that spread). At the time of the report, RASH PRURITIC (Delayed reaction with a red itchy rash that spread) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications were reported.    This case was linked to MOD21-041738, MOD21-041779 (Linked Report).; Sender's Comments:  MOD21-041738:same reporter MOD21-041779:same reporter
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: I was having some unusual side effects; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (I was having some unusual side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Kidney transplant.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (I was having some unusual side effects). At the time of the report, ADVERSE EVENT (I was having some unusual side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  No treatment medications provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: No specific follow-up information recorded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling
Clinical narrative: Left upper arm burning, hurting; large red welt on entire left; Swelling/welt grew to about two inches long by one inch across; Redness; Covid arm; Itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE URTICARIA (large red welt on entire left), VACCINATION SITE SWELLING (Swelling/welt grew to about two inches long by one inch across) and VACCINATION SITE ERYTHEMA (Redness) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy and Drug allergy (Aleve). Concomitant products included MAGNESIUM for Foot cramps, BOSWELLIA SERRATA, CURCUMA LONGA, DL-PHENYLALANINE, NATTOKINASE (CURAMIN) for Inflammation, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 20-Jan-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE SWELLING (Swelling/welt grew to about two inches long by one inch across) and VACCINATION SITE ERYTHEMA (Redness). On 18-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (large red welt on entire left). On an unknown date, the patient experienced VACCINATION SITE PAIN (Left upper arm burning, hurting). The patient was treated with CORTISONE for Allergic reaction, at an unspecified dose and frequency. On 28-Feb-2021, VACCINATION SITE URTICARIA (large red welt on entire left) had resolved. At the time of the report, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE SWELLING (Swelling/welt grew to about two inches long by one inch across), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PAIN (Left upper arm burning, hurting) outcome was unknown.            Treatment also included other anti-itch lotions.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up was received on 18-MAY-2021 which contained the contact Information of the patient.. On 25-Jul-2021: Patient information, allergy details, suspect product dosage details with lot number and facility information updated. New events left upper arm burning, hurting and large red welt on entire left were added. Concomitant and treatment medications were updated.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site urticaria
Clinical narrative: Left upper arm burning, hurting; large red welt on entire left; Swelling/welt grew to about two inches long by one inch across; Redness; Covid arm; Itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE URTICARIA (large red welt on entire left), VACCINATION SITE SWELLING (Swelling/welt grew to about two inches long by one inch across) and VACCINATION SITE ERYTHEMA (Redness) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy and Drug allergy (Aleve). Concomitant products included MAGNESIUM for Foot cramps, BOSWELLIA SERRATA, CURCUMA LONGA, DL-PHENYLALANINE, NATTOKINASE (CURAMIN) for Inflammation, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 20-Jan-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE SWELLING (Swelling/welt grew to about two inches long by one inch across) and VACCINATION SITE ERYTHEMA (Redness). On 18-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (large red welt on entire left). On an unknown date, the patient experienced VACCINATION SITE PAIN (Left upper arm burning, hurting). The patient was treated with CORTISONE for Allergic reaction, at an unspecified dose and frequency. On 28-Feb-2021, VACCINATION SITE URTICARIA (large red welt on entire left) had resolved. At the time of the report, VACCINATION SITE REACTION (Covid arm), VACCINATION SITE PRURITUS (Itching), VACCINATION SITE SWELLING (Swelling/welt grew to about two inches long by one inch across), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PAIN (Left upper arm burning, hurting) outcome was unknown.            Treatment also included other anti-itch lotions.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up was received on 18-MAY-2021 which contained the contact Information of the patient.. On 25-Jul-2021: Patient information, allergy details, suspect product dosage details with lot number and facility information updated. New events left upper arm burning, hurting and large red welt on entire left were added. Concomitant and treatment medications were updated.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Exposure during pregnancy, Glucose tolerance test, Pain in extremity, Pregnancy test
Clinical narrative: soreness in arm; Vaccination site pruritus; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm), VACCINATION SITE PRURITUS (Vaccination site pruritus) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] from 21-Jan-2021 to an unknown date for Prenatal care.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 19-Dec-2020 and the estimated date of delivery was 25-Sep-2021. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in arm), VACCINATION SITE PRURITUS (Vaccination site pruritus) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  ninth week of the pregnancy.  At the time of the report, PAIN IN EXTREMITY (soreness in arm), VACCINATION SITE PRURITUS (Vaccination site pruritus) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, Pregnancy test: positive (Positive) positive. On 21-Jan-2021, Blood test: normal (normal) normal. On 21-Jan-2021, Glucose tolerance test: normal (normal) normal. On 21-Jan-2021, Urine analysis: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis, Vaccination site pruritus
Clinical narrative: soreness in arm; Vaccination site pruritus; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm), VACCINATION SITE PRURITUS (Vaccination site pruritus) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] from 21-Jan-2021 to an unknown date for Prenatal care.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 19-Dec-2020 and the estimated date of delivery was 25-Sep-2021. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in arm), VACCINATION SITE PRURITUS (Vaccination site pruritus) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  ninth week of the pregnancy.  At the time of the report, PAIN IN EXTREMITY (soreness in arm), VACCINATION SITE PRURITUS (Vaccination site pruritus) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, Pregnancy test: positive (Positive) positive. On 21-Jan-2021, Blood test: normal (normal) normal. On 21-Jan-2021, Glucose tolerance test: normal (normal) normal. On 21-Jan-2021, Urine analysis: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash erythematous, Vaccination site erythema
Clinical narrative: Red rash in my arm; Itchy; Persistent arm soreness; Pink spot at injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash in my arm), PRURITUS (Itchy), PAIN IN EXTREMITY (Persistent arm soreness) and VACCINATION SITE ERYTHEMA (Pink spot at injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Dyslipidemia.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (Persistent arm soreness) and VACCINATION SITE ERYTHEMA (Pink spot at injection site). On an unknown date, the patient experienced RASH ERYTHEMATOUS (Red rash in my arm) and PRURITUS (Itchy). At the time of the report, RASH ERYTHEMATOUS (Red rash in my arm), PRURITUS (Itchy), PAIN IN EXTREMITY (Persistent arm soreness) and VACCINATION SITE ERYTHEMA (Pink spot at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications reported were, blood pressure medication and cholesterol medication. No treatment medication information was reported.   This case was linked to MOD-2021-097630 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Updated events of 1st dose (vaccination site erythema, pain in extremity).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Myalgia, Pain in extremity, Vaccination site erythema
Clinical narrative: Her leg is sore; Legs weak; Muscle ache; Joint pain from her knees down to her feet; Redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her leg is sore), ASTHENIA (Legs weak), MYALGIA (Muscle ache), ARTHRALGIA (Joint pain from her knees down to her feet) and VACCINATION SITE ERYTHEMA (Redness around the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K28 and 039K28) for COVID-19 vaccination.     The patient's past medical history included Jaundice, Heart murmur, Bile duct stent insertion and Aortic valve replacement in 2000. Concurrent medical conditions included Hypertension. Concomitant products included METOPROLOL and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Her leg is sore), ASTHENIA (Legs weak), MYALGIA (Muscle ache), ARTHRALGIA (Joint pain from her knees down to her feet) and VACCINATION SITE ERYTHEMA (Redness around the injection site). At the time of the report, PAIN IN EXTREMITY (Her leg is sore), ASTHENIA (Legs weak), MYALGIA (Muscle ache) and ARTHRALGIA (Joint pain from her knees down to her feet) outcome was unknown and VACCINATION SITE ERYTHEMA (Redness around the injection site) had resolved.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: Sore arm; Tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and HEADACHE (Headache) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown.            Concomitant medications are not provided. Treatment information does not provided. The action taken with the drug was Not applicable.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Fatigue, Headache, Illness
Clinical narrative: very sleepy; sick; slight headache; chills; tiredness; pain in her stomach/my stomach hurt; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (pain in her stomach/my stomach hurt), ILLNESS (sick), SOMNOLENCE (very sleepy), NAUSEA (nauseous) and HEADACHE (slight headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer. Concomitant products included LOSARTAN and AMLODIPINE for an unknown indication.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (pain in her stomach/my stomach hurt), NAUSEA (nauseous), CHILLS (chills) and FATIGUE (tiredness). On 27-Feb-2021, the patient experienced ILLNESS (sick) and HEADACHE (slight headache). On an unknown date, the patient experienced SOMNOLENCE (very sleepy). On 01-Mar-2021, ILLNESS (sick), NAUSEA (nauseous), HEADACHE (slight headache), CHILLS (chills) and FATIGUE (tiredness) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (pain in her stomach/my stomach hurt) had not resolved and SOMNOLENCE (very sleepy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list also included Trazadone 5mg. Treatment information included Tylenol.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Somnolence
Clinical narrative: very sleepy; sick; slight headache; chills; tiredness; pain in her stomach/my stomach hurt; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (pain in her stomach/my stomach hurt), ILLNESS (sick), SOMNOLENCE (very sleepy), NAUSEA (nauseous) and HEADACHE (slight headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer. Concomitant products included LOSARTAN and AMLODIPINE for an unknown indication.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (pain in her stomach/my stomach hurt), NAUSEA (nauseous), CHILLS (chills) and FATIGUE (tiredness). On 27-Feb-2021, the patient experienced ILLNESS (sick) and HEADACHE (slight headache). On an unknown date, the patient experienced SOMNOLENCE (very sleepy). On 01-Mar-2021, ILLNESS (sick), NAUSEA (nauseous), HEADACHE (slight headache), CHILLS (chills) and FATIGUE (tiredness) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (pain in her stomach/my stomach hurt) had not resolved and SOMNOLENCE (very sleepy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list also included Trazadone 5mg. Treatment information included Tylenol.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Headache, Influenza like illness, Malaise
Clinical narrative: Felt sick that night all night, slight fever, flu-like symptoms, aching; Felt sick that night all night, slight fever, flu-like symptoms, aching; I was aching my bones were aching; Headache; Shoulders did hurt; Started to feel bad; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Started to feel bad), MALAISE (Felt sick that night all night, slight fever, flu-like symptoms, aching), INFLUENZA LIKE ILLNESS (Felt sick that night all night, slight fever, flu-like symptoms, aching), MYALGIA (I was aching my bones were aching) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FENTANYL and DULOXETINE for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Dec-2020, the patient experienced PYREXIA (slight fever). On 25-Feb-2021, the patient experienced FEELING ABNORMAL (Started to feel bad). On 27-Feb-2021, the patient experienced MALAISE (Felt sick that night all night, slight fever, flu-like symptoms, aching), INFLUENZA LIKE ILLNESS (Felt sick that night all night, slight fever, flu-like symptoms, aching), MYALGIA (I was aching my bones were aching), HEADACHE (Headache) and ARTHRALGIA (Shoulders did hurt). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 50 milligram and ONDANSETRONI HYDROCHLORIDUM DIHYDRICUM for Nausea, at a dose of 4 milligram. At the time of the report, FEELING ABNORMAL (Started to feel bad), MALAISE (Felt sick that night all night, slight fever, flu-like symptoms, aching), INFLUENZA LIKE ILLNESS (Felt sick that night all night, slight fever, flu-like symptoms, aching), MYALGIA (I was aching my bones were aching), HEADACHE (Headache), ARTHRALGIA (Shoulders did hurt) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Felt sick that night all night, slight fever, flu-like symptoms, aching; Felt sick that night all night, slight fever, flu-like symptoms, aching; I was aching my bones were aching; Headache; Shoulders did hurt; Started to feel bad; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Started to feel bad), MALAISE (Felt sick that night all night, slight fever, flu-like symptoms, aching), INFLUENZA LIKE ILLNESS (Felt sick that night all night, slight fever, flu-like symptoms, aching), MYALGIA (I was aching my bones were aching) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FENTANYL and DULOXETINE for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Dec-2020, the patient experienced PYREXIA (slight fever). On 25-Feb-2021, the patient experienced FEELING ABNORMAL (Started to feel bad). On 27-Feb-2021, the patient experienced MALAISE (Felt sick that night all night, slight fever, flu-like symptoms, aching), INFLUENZA LIKE ILLNESS (Felt sick that night all night, slight fever, flu-like symptoms, aching), MYALGIA (I was aching my bones were aching), HEADACHE (Headache) and ARTHRALGIA (Shoulders did hurt). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 50 milligram and ONDANSETRONI HYDROCHLORIDUM DIHYDRICUM for Nausea, at a dose of 4 milligram. At the time of the report, FEELING ABNORMAL (Started to feel bad), MALAISE (Felt sick that night all night, slight fever, flu-like symptoms, aching), INFLUENZA LIKE ILLNESS (Felt sick that night all night, slight fever, flu-like symptoms, aching), MYALGIA (I was aching my bones were aching), HEADACHE (Headache), ARTHRALGIA (Shoulders did hurt) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.